Australia markets closed

InMed Pharmaceuticals Inc. (INM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2267-0.0108 (-4.55%)
At close: 04:00PM EDT
0.2379 +0.01 (+4.94%)
After hours: 05:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.89M
Enterprise value -4.64M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.24
Price/book (mrq)0.17
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.57
52-week change 3-80.43%
S&P500 52-week change 323.76%
52-week high 32.0800
52-week low 30.2150
50-day moving average 30.2850
200-day moving average 30.4331

Share statistics

Avg vol (3-month) 3627.9k
Avg vol (10-day) 31.18M
Shares outstanding 58.36M
Implied shares outstanding 68.36M
Float 88.28M
% held by insiders 10.99%
% held by institutions 18.21%
Shares short (15 May 2024) 476.72k
Short ratio (15 May 2024) 40.2
Short % of float (15 May 2024) 40.92%
Short % of shares outstanding (15 May 2024) 40.92%
Shares short (prior month 15 Apr 2024) 4114.49k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 July 2020
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 307 Sept 2022

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -108.01%
Operating margin (ttm)-153.18%

Management effectiveness

Return on assets (ttm)-29.56%
Return on equity (ttm)-51.73%

Income statement

Revenue (ttm)5.63M
Revenue per share (ttm)0.93
Quarterly revenue growth (yoy)13.40%
Gross profit (ttm)N/A
EBITDA -6.42M
Net income avi to common (ttm)-6.08M
Diluted EPS (ttm)-0.5400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.64M
Total cash per share (mrq)0.92
Total debt (mrq)1.07M
Total debt/equity (mrq)9.64%
Current ratio (mrq)6.58
Book value per share (mrq)1.75

Cash flow statement

Operating cash flow (ttm)-6.61M
Levered free cash flow (ttm)-4.34M